Issue 14 l[removed]l Disease courses in MS MSIF14 pp01 cover.indd 1

First Page		Document Content
Date: 2014-10-14 05:17:55 Medicine Treatment of multiple sclerosis Fred D. Lublin Corinne Goldsmith Dickinson Center for Multiple Sclerosis Glatiramer acetate Mitoxantrone Natalizumab Laquinimod Fingolimod Multiple sclerosis Immunology Immune system		Issue 14 l[removed]l Disease courses in MS MSIF14 pp01 cover.indd 1 Add to Reading List Source URL: www.msif.org Download Document from Source Website File Size: 1,75 MB Share Document on Facebook

	Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio DocID: 1qn6Z - View Document
	Stellungnahme der AkdÄ zur Nutzenbewertung von Fingolimod (neues Anwendungsgebiet) DocID: 1n48S - View Document
	Rote-Hand-Brief zu Gilenya® (Fingolimod) DocID: 1h06f - View Document
	Biotin (Cerenday) for permanent disability related to multiple sclerosis relapses – add on therapy to current immunomodulators DocID: 1fWCE - View Document
	Bijlage bij email betreffende vergoeding fingolimod juliArtikel uit MenSen nr. 4 Samenvatting aanvullende voorwaarden zoals is overeengekomen op 4 juni 2013 met CVZ, VWS, zorgverzekeraars, MS Vereniging Nederland, DocID: 1ea9n - View Document